Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Malignant Melanoma

Free Subscription 02.03.2026 1 Am J Dermatopathol 3 Ann Surg Oncol 1 Anticancer Res 2 BMC Cancer 3 Br J Dermatol 1 Cancer Lett 4 J Am Acad Dermatol 1 Melanoma Res 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. LIU J, Liu L, An X
   Deep Learning for Classification and Prognosis of Melanoma in Whole-Slide Images: A Review.
   Am J Dermatopathol. 2026 Feb 26. doi: 10.1097/DAD.0000000000003239.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

2. RIAZ N, Leong SP, Kashani-Sabet M, White RL Jr, et al
   ASO Visual Abstract: Prognostic Value of Non-Nodal Regional Metastases in Predicting Sentinel Lymph Node Status in Cutaneous Melanoma: Multicenter Analysis of the Sentinel Lymph Node Working Group Database.
   Ann Surg Oncol. 2026 Feb 26. doi: 10.1245/s10434-026-19284.
   PubMed        
   
   
3. MOR E, Apte S, Bressel M, Broman KK, et al
   Evaluation of Clinical Outcomes and Pattern of Recurrence in Patients with Cutaneous Melanoma and Sentinel Lymph Node Positivity Since the Publication of the MSLT-2 Trial.
   Ann Surg Oncol. 2026 Feb 26. doi: 10.1245/s10434-026-19260.
   PubMed         Abstract available
   
   
4. MAYHEW MM, Tocco EG, Mercante MG, Kuchimanchi N, et al
   ASO Visual Abstract: Patterns and Predictors of Sentinel Lymph Node Biopsy Utilization in High- and Low-Risk Thin Melanomas.
   Ann Surg Oncol. 2026 Feb 24. doi: 10.1245/s10434-026-19274.
   PubMed        
   
   

   
   Anticancer Res

5. MAIMON O, Nisman B, Ben-David I, Kuznetz A, et al
   Autologous Tumor Vaccination in Melanoma and Colon Cancer Patients With Recurrent Liver Metastases: A Case Series.
   Anticancer Res. 2026;46:1569-1575.
   PubMed         Abstract available
   
   

   
   BMC Cancer

6. ESSA MEA, Noori H, Butler J, Ahmed AA, et al
   Gut microbial signatures and immunotherapy outcomes in NSCLC and melanoma: a systematic review and meta-analysis.
   BMC Cancer. 2026 Feb 21. doi: 10.1186/s12885-026-15763.
   PubMed        
   
   
7. DE MATTIA M, Boutros A, Delucchi V, Blondeaux E, et al
   End?of?life care in advanced melanoma: a retrospective cohort study from an Italian comprehensive cancer center.
   BMC Cancer. 2026 Feb 21. doi: 10.1186/s12885-026-15762.
   PubMed        
   
   

   
   Br J Dermatol

8. BOOTH L, Chen X, Stoker K, McCraw A, et al
   Phenotypic, functional, prognostic and predictive significance of B-cell and antibody responses in human melanoma: A scoping review.
   Br J Dermatol. 2026 Feb 26:ljag074. doi: 10.1093.
   PubMed         Abstract available
   
   
9. MARJANOVIC M, Mikiver R, Nielsen K, Isaksson K, et al
   Comment on 'Contrasting Survival Outcomes and Patient Characteristics in 5,815 Patients with Stage II and III Melanoma: A Nationwide Population-Based Registry Study from Sweden': reply from authors.
   Br J Dermatol. 2026 Feb 25:ljag059. doi: 10.1093.
   PubMed        
   
   
10. LODDE G, Dollani J, Galetzka W, Mohr P, et al
    Melanoma of unknown primary shows oncogenic pattern and clinical course of sun-exposed melanoma.
    Br J Dermatol. 2026 Feb 20:ljaf499. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Cancer Lett

11. XU S, Huang Z, Li Y, Lu L, et al
    Emerging biomarkers in melanoma: Bridging molecular discovery and precision oncology.
    Cancer Lett. 2026 Feb 22:218359. doi: 10.1016/j.canlet.2026.218359.
    PubMed         Abstract available
    
    

    
    J Am Acad Dermatol

12. ZHOU S, Ying H, Zheng J, Cheng S, et al
    Anatomic Location as a Prognostic Factor in Acral Melanoma: True Driver or Molecular Surrogate?
    J Am Acad Dermatol. 2026 Feb 20:S0190-9622(26)00278.
    PubMed        
    
    
13. NAVARRETE-DECHENT C, Pietkiewicz P, Abarzua-Araya A, Aguero R, et al
    Ultraviolet-induced fluorescent dermoscopy for the diagnosis of skin tumors: A multicenter study.
    J Am Acad Dermatol. 2026;94:835-842.
    PubMed         Abstract available
    
    
14. MELHORANSE GOUVEIA B, Wong T, Ferguson PM, Glanz A, et al
    In vivo cutaneous confocal microscopy for diagnosing the lentigo maligna spectrum: A multicentre prospective study and proposal of a lentigo maligna spectrum score.
    J Am Acad Dermatol. 2026;94:819-827.
    PubMed         Abstract available
    
    
15. KENT JA, Suhl S, Schreidah CM, Lapolla BA, et al
    Estimation of Surveillance Costs for Melanoma Survivors Based on 2025 NCCN Guidelines.
    J Am Acad Dermatol. 2026 Feb 21:S0190-9622(26)00285.
    PubMed        
    
    

    
    Melanoma Res

16. ZHOU MH, Li W, Carpenter AK, Lipner SR, et al
    Tebentafusp-associated dermatological adverse events in patients with metastatic uveal melanoma: a single-center retrospective cohort study.
    Melanoma Res. 2026;36:143-144.
    PubMed        
    
    

    
    PLoS One

17. OH DE, Kee G, Oh JH, Kim W, et al
    Annotation-free prediction of immunotherapy response in melanoma using single-cell transcriptomic data.
    PLoS One. 2026;21:e0343633.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum